ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,454, issued on April 21, was assigned to SAIBA AG (Pfaffikon, Switzerland).
"Modified virus-like particles of CMV" was invented by Martin Bachmann (Ramismuhle, Switzerland), Andris Zeltins (Riga, Latvia) and Paul Pumpens (Riga, Latvia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to virus-like particles of plant virus Cucumber Mosaic Virus (CMV), and in particular to modified VLPs of CMV comprising Th cell epitopes, in particular universal Th cell epitopes. Furthermore, these modified VLPs serve as, preferably, vaccine platform, for generating immune responses, in particular antibody responses, against antigens linked...